Cargando…
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
OBJECTIVES: To systematically evaluate the effectiveness and safety of neoadjuvant immunotherapy for patients with non–small cell lung cancer (NSCLC). METHODS: Randomized controlled trials of neoadjuvant immunotherapy in treating patients with NSCLC were comprehensively retrieved from electronic dat...
Autores principales: | Yu, Shaofu, Zhai, Shasha, Gong, Qian, Xiang, Chunhong, Gong, Jianping, Wu, Lin, Pu, Xingxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10589427/ https://www.ncbi.nlm.nih.gov/pubmed/37749786 http://dx.doi.org/10.1097/COC.0000000000001046 |
Ejemplares similares
-
Perivascular epithelioid cell tumor of the lung: A case report and literature review
por: Yu, Shaofu, et al.
Publicado: (2022) -
Neoadjuvant immunotherapy or chemoimmunotherapy in non-small cell lung cancer: a systematic review and meta-analysis
por: Jiang, Juan, et al.
Publicado: (2022) -
Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis
por: Wang, He, et al.
Publicado: (2022) -
Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer
por: Guo, Hanfei, et al.
Publicado: (2021) -
Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance
por: Pu, Xingxiang, et al.
Publicado: (2018)